Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000599357 | SCV000710713 | pathogenic | not provided | 2018-02-19 | criteria provided, single submitter | clinical testing | The c.12197_12209del13insTGGGA variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant causes a frameshift starting with codon Glycine 4066, changes this amino acid to a Valine residue and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Gly4066ValfsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is not observed in large population cohorts (Lek et al., 2016). In summary, we consider the variant to be pathogenic. |